The Prevalence of Microalbuminuria in Type 2 Diabetes Mellitus Patients in Ilanur Mother and Child Hospital Tangerang
Abstract
Type 2 diabetes mellitus (DMT2) is still a global health problem. If not treated properly, DMT2 can lead to chronic conditions such as albuminuria, a condition in which albumin is found in the urine due to decreased kidney function. The presence of elevated albumin levels in the form of microalbuminuria indicates that DMT2 disease has progressed. This study aims to describe the prevalence of microalbuminuria in DMT2 patients who have urine microalbumin examined at RSIA Ilanur, Tangerang City. This type of research is descriptive, with a cross-sectional approach and a total of 28 respondents. The method used to examine microalbuminuria is fluorescence immunoassay using the Boditech AFIAS instrument. The urine microalbumin profile obtained was then analyzed based on gender, age, and duration of suffering from DMT2. Based on the research, it can be concluded that the majority of DMT2-sufferers are women. The age range of most sufferers is in the age group of 51–60 years. Meanwhile, based on the duration of suffering from DMT2, the categories <5 years and ≥5 years both have a 50% frequency distribution. Based on the microalbuminuria examination profile, both male and female groups showed a proportion of 75% microalbuminuria incidence. The number of DMT2 sufferers who experienced microalbuminuria was higher in the age group of 51–60 years (73.3%). Meanwhile, based on the duration of suffering from DMT2, the group of respondents <5 years tended to have higher cases of microalbuminuria (78.6%) in the population studied.
Downloads
References
Amelia R., Sari D.K., Muzasti R.A., Fujiati I.I., Wijaya H. (2021). Early detection of diabetic nephropathy based on albumin creatinine ratio (ACR) in type 2 diabetes mellitus patients in Medan, Indonesia. Fam Med Prim Care Rev. 23(2): 135–138, doi: https://doi.org/10.5114/fmpcr.2021.105903.
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia. 2019. Hasil Riset Kesehatan Dasar 2018. Jakarta: Balitbangkes Kemenkes RI.
Carranza, K., et al. (2015). Cellular and Molecular Aspects of Diabetic Nephropathy and The Role of VEGF-A.
Cendra, S., Moeis, E., & Langi, Y. (2014). Gambaran Kadar Albuminuria pada Subjek Diabetes Melitus dengan dan Tanpa Penyakit Jantung Koroner. e-CliniC, 2(2).
Chamberlain, J.J., Rhinehart, A.S., Shaefer Jr, C.F., & Neuman, A. (2016). Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Annals of internal medicine, 164(8), 542-552.
Dinas Kesehatan Provinsi Banten. 2021. Profil Kesehatan Banten Tahun 2021. Serang: Dinas Kesehatan Provinsi Banten.
Elfiani, H.R, & Hakir, M. (2019). Hubungan Antara Kadar TGF-B1 Dengan Kadar Albumin Dalam Urin Pasien DM Tipe-2 Dengan Nefropati Diabetik. JMJ. 7(1): 73–81.
Imelda, F., Susalit, E., and Marbun, M.B.M. (2017). Clinical Features and Quality of Life in End Stage Renal Disease Patients Undergoing Hemodialysis Twice A Week Compared to Thrice A Week. Jurnal Penyakit Dalam Indonesia: 4(3): 128-136. DOI: 10.7454/jpdi.v4i3.139.
Indriani, V., Siswandari, W., & Andreas, T.L. (2021). Effect of Glycosylated Hemoglobin with Microalbuminuria and Albumin Creatinine Ratio in Type 2 Diabetes. Pakistan Journal of Medical & Health Science: 15(7): 1974-1977.
International Diabetes Federation. 2022. IDF Diabetes Atlas 2021. https://diabetesatlas.org/. Diakses pada 14 April 2023.
Lamb, E., Newman, D., Price, C. (2006). Kidney function tests. In: Burtis C, Ashwood E, Bruns D, eds. Tietz Textbook of Clinical Chemistry, 4th ed. St. Louis, MO: Elsevier Saunders.
Lewandrowski, K. (2017). The Clinical Utility of Urinary Microalbumin in the Management of Diabetes Mellitus. Point of Care, 16(1), 34-36.
Lucas, S. (2022). Sindroma Kardiorenal. JAI (Jurnal Anestesiologi Indonesia). 14(3): 257-273.
Nasreen, T., Ferdousi, S., Alam, K., Sultana, T., Dipta, T.F., & Selim, S. (2018). Association of serum magnesium level with microalbumin in urine of newly detected type-2 diabetes mellitus. Northern International Medical College Journal, 9(2): 291-294.
Raja, S. A., Chong, V.H., Rahman, N.A., Shakir, L.M., & Knights, J. (2022). Prevalence and associated factors of diabetic retinopathy among type 2 diabetes mellitus patients in Brunei Darussalam: a cross-sectional study. Korean Journal of Ophthalmology: KJO. 36(1):26.
Ritz, E., Orth, S.R. (1999). Nephropathy in patients with Type-2 diabetes mellitus. New Engl J Med. 341(15):1127-1133. doi:10.1056/NEJM199910073411506.
Saputro, A.A., & Rusidah, Y. (2023). Analisis Kadar Mikroalbuminuria Pasien Lansia Dengan Riwayat Diabetes Mellitus TIPE II Di Kabupaten Kudus. In Prosiding University Research Colloquium (pp. 157-165).
Shah, P.B., Acharya, A., Shrestha, S., & Shrestha, S. (2017). Role of HbA1c and Microalbumin as an Early Risk Marker of Diabetic Nephropathy. Int. J. Health Sci. Res. 7(2): 141-145.
Tapia, C., & Bashir, K. (2021). Nephrotic Syndrome. StatPearls. Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK470444/.
Tripitara, Hidayati, T., Sun, S., Akrom. 2023. Early detection methods of chronic diabetic nephropathy in diabetes mellitus patients in primary health services. Bali Medical Journal. 12(1): 530-533. DOI: 10.15562/bmj.v12i1.3740.
Vaidya, S.R., & Aeddula, N.R. (2021). Chronic Renal Failure. The Scientific Basis of Urology, Second Edition, 257–264. doi: 10.29309/tpmj/2009.16.04.2736.
Yosdimyati, L. (2021) The Relationship between Microalbumin Levels and HbA1c in People at Risk for Type 2 Diabetes Mellitus. Medicra (Journal of Medical Laboratory Science/Technology). 4(2): 88-92. doi: 10.21070/medicra.v4i2.1612.
Copyright (c) 2023 Ahmad Yani, Rizka Lestari Widhayanti, Budi Siswanto
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Noncommunicable Diseases Prevention and Control applies the Creative Commons Attribution 4.0 International (CC BY) License, or other comparable licenses that allow free and unrestricted use to articles we publish. If you submit your manuscript for publication by the Journal of Noncommunicable Diseases Prevention and Control, you agree to have the CC BY license applied to your work. If your institution or funder requires your work or materials to be published under a different license or dedicated to the public domain - for example, Creative Commons 1.0 Universal (CC0) or Open Governmental License - this is permitted for those licenses where the terms are equivalent to or more permissive than CC BY.
